Канал: AZ Precision Medicine

Best Practices for Utilizing Alternative Service Models for Genetic Counseling

Best Practices for Utilizing Alternative Service Models for Genetic Counseling

Genetic Testing: How Much Does it Really Cost?

Genetic Testing: How Much Does it Really Cost?

Gene Mutations: Inherited vs Acquired

Gene Mutations: Inherited vs Acquired

Informed Consent for Genetic Testing: Before the Test, Learn What to Expect

Informed Consent for Genetic Testing: Before the Test, Learn What to Expect

What Your Genetic Test Means for Your Family Members

What Your Genetic Test Means for Your Family Members

How Does the Genetic Information Nondiscrimination Act (GINA) Protect You?

How Does the Genetic Information Nondiscrimination Act (GINA) Protect You?

Episode 5: Talking With Your Patient About Testing

Episode 5: Talking With Your Patient About Testing

Leading The Way: Starting With Pilot Efforts With Ms Dana Clark

Leading The Way: Starting With Pilot Efforts With Ms Dana Clark

Leading the Way: Revamped Workflows With Dr Robert Neff

Leading the Way: Revamped Workflows With Dr Robert Neff

Leading The Way: Employing User-Friendly Tracking Systems With Ms Dana Clark

Leading The Way: Employing User-Friendly Tracking Systems With Ms Dana Clark

Leading the Way: Need to Standardize Biomarker Testing With Dr Michelle Shiller

Leading the Way: Need to Standardize Biomarker Testing With Dr Michelle Shiller

Leading the Way: Design a Standard Protocol With Dr Michelle Shiller

Leading the Way: Design a Standard Protocol With Dr Michelle Shiller

Leading the Way: Becoming a Testing Champion With Dr Michelle Shiller

Leading the Way: Becoming a Testing Champion With Dr Michelle Shiller

Leading the Way: Develop a Strong Relationship With IT With Ms Courtney Rice

Leading the Way: Develop a Strong Relationship With IT With Ms Courtney Rice

Leading the Way: Monitor Testing Orders With Commercial Labs With Dr Robert Neff

Leading the Way: Monitor Testing Orders With Commercial Labs With Dr Robert Neff

Leading The Way: Negotiating Responsibilities With Ms Dana Clark

Leading The Way: Negotiating Responsibilities With Ms Dana Clark

Leading the Way: Form a Dedicated Precision Oncology Committee With Ms Courtney Rice

Leading the Way: Form a Dedicated Precision Oncology Committee With Ms Courtney Rice

Episode 4: To Test or Not to Test—Tips for How To Implement a Testing Flow in Your Practice

Episode 4: To Test or Not to Test—Tips for How To Implement a Testing Flow in Your Practice

Episode 3: HRD What? HRD Why?

Episode 3: HRD What? HRD Why?

Episode 2: Evolution of Testing in Ovarian Cancer

Episode 2: Evolution of Testing in Ovarian Cancer

Episode 1: Introduction to this Podcast Series

Episode 1: Introduction to this Podcast Series

Leading the Way: Approaches in Biomarker Testing For Cancer Treatment With Dana Clark

Leading the Way: Approaches in Biomarker Testing For Cancer Treatment With Dana Clark

Leading the Way: Approaches in Biomarker Testing with Robert Neff, MD and Courtney Rice, LCGC

Leading the Way: Approaches in Biomarker Testing with Robert Neff, MD and Courtney Rice, LCGC

Leading the Way: Approaches in Biomarker Testing For Cancer Treatment With Dr Michelle Shiller

Leading the Way: Approaches in Biomarker Testing For Cancer Treatment With Dr Michelle Shiller

The Rationale for HRD Genomic Instability Testing in Patients with Advanced Ovarian Cancer

The Rationale for HRD Genomic Instability Testing in Patients with Advanced Ovarian Cancer

The Importance of Molecular Testing for HRR Gene Mutations in Patients With mCRPC

The Importance of Molecular Testing for HRR Gene Mutations in Patients With mCRPC

Understanding the Importance of Integrated Care

Understanding the Importance of Integrated Care

Integrated Care and Personalizing Treatment

Integrated Care and Personalizing Treatment

Embedding Biomarker Testing Protocols

Embedding Biomarker Testing Protocols

Maintenance Therapy in Ovarian Cancer

Maintenance Therapy in Ovarian Cancer

Integrating Germline and Somatic Testing

Integrating Germline and Somatic Testing

mNSCLC with both PD-L1 and an Actionable Mutation

mNSCLC with both PD-L1 and an Actionable Mutation

Optimizing Biomarker Testing for Patients with Metastatic Prostate Cancer

Optimizing Biomarker Testing for Patients with Metastatic Prostate Cancer

Integrating Plasma Testing for Actionable Mutations in mNSCLC

Integrating Plasma Testing for Actionable Mutations in mNSCLC

Lack of Evidence for Use of IO Therapy in First-Line Treatment of EGFRm mNSCLC

Lack of Evidence for Use of IO Therapy in First-Line Treatment of EGFRm mNSCLC

The Role of Molecular Testing in Advanced Ovarian Cancer

The Role of Molecular Testing in Advanced Ovarian Cancer

Homologous Recombination Deficiency and Cancer Care

Homologous Recombination Deficiency and Cancer Care

Classifying Nodal Involvement in NSCLC

Classifying Nodal Involvement in NSCLC

Importance of Pathologic Staging in NSCLC

Importance of Pathologic Staging in NSCLC

Role of BRCA Mutations in BC

Role of BRCA Mutations in BC